Annual Cash & Cash Equivalents
$4.60 M
+$4.25 M+1211.28%
December 31, 2023
Summary
- As of February 8, 2025, MIRA annual cash & cash equivalents is $4.60 million, with the most recent change of +$4.25 million (+1211.28%) on December 31, 2023.
- During the last 3 years, MIRA annual cash & cash equivalents has risen by +$1.79 million (+63.82%).
- MIRA annual cash & cash equivalents is now at all-time high.
Performance
MIRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.14 M
+$1.32 M+46.77%
September 30, 2024
Summary
- As of February 8, 2025, MIRA quarterly cash and cash equivalents is $4.14 million, with the most recent change of +$1.32 million (+46.77%) on September 30, 2024.
- Over the past year, MIRA quarterly cash and cash equivalents has dropped by -$458.00 thousand (-9.95%).
- MIRA quarterly cash and cash equivalents is now -29.37% below its all-time high of $5.87 million, reached on September 30, 2023.
Performance
MIRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MIRA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1211.3% | -9.9% |
| 3 y3 years | +63.8% | +1080.8% |
| 5 y5 years | +63.8% | +1080.8% |
MIRA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1211.3% | -29.4% | >+9999.0% |
| 5 y | 5-year | at high | +1211.3% | -29.4% | >+9999.0% |
| alltime | all time | at high | +1211.3% | -29.4% | >+9999.0% |
MIRA Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.14 M(+46.8%) |
| Jun 2024 | - | $2.82 M(-20.0%) |
| Mar 2024 | - | $3.53 M(-23.3%) |
| Dec 2023 | $4.60 M | $4.60 M(-21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $5.87 M(>+9900.0%) |
| Jun 2023 | - | $24.80 K(+1807.7%) |
| Mar 2023 | - | $1300.00(-99.6%) |
| Dec 2022 | $351.00 K(-87.5%) | $351.00 K |
| Dec 2021 | $2.81 M | - |
FAQ
- What is MIRA Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MIRA Pharmaceuticals?
- What is MIRA Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is MIRA Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MIRA Pharmaceuticals?
- What is MIRA Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is MIRA Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of MIRA is $4.60 M
What is the all time high annual cash & cash equivalents for MIRA Pharmaceuticals?
MIRA Pharmaceuticals all-time high annual cash & cash equivalents is $4.60 M
What is MIRA Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, MIRA annual cash & cash equivalents has changed by +$4.25 M (+1211.28%)
What is MIRA Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MIRA is $4.14 M
What is the all time high quarterly cash and cash equivalents for MIRA Pharmaceuticals?
MIRA Pharmaceuticals all-time high quarterly cash and cash equivalents is $5.87 M
What is MIRA Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, MIRA quarterly cash and cash equivalents has changed by -$458.00 K (-9.95%)